Tuesday, July 5, 2016

BRIEF-Biogen and AbbVie's drug approved in EU

* Biogen and AbbVie's once-monthly zinbryta(tm) (daclizumab)

approved in European Union for treatment of multiple sclerosis

Read more
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)